Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Karyopharm Therapeut (NQ: KPTI ) 0.7820 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.7820 Bid (Size) 0.7700 (8) Ask (Size) 0.8425 (56) Prev. Close 0.7820 Today's Range 0.7820 - 0.7820 52wk Range 0.6174 - 1.950 Shares Outstanding 114,010,448 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript August 06, 2024 KPTI earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD -13.23% -13.23% 1 Month -24.08% -24.08% 3 Month -18.74% -18.74% 6 Month -41.20% -41.20% 1 Year -42.50% -42.50% More News Read More The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom May 23, 2024 Via InvestorPlace Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript May 08, 2024 Via The Motley Fool Topics Earnings Exposures Financial KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 Via The Motley Fool Topics Earnings Exposures Financial Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga Karyopharm Therapeutics's Earnings: A Preview February 28, 2024 Via Benzinga Earnings Preview For Karyopharm Therapeutics November 01, 2023 Via Benzinga 6 Analysts Have This to Say About Karyopharm Therapeutics August 03, 2023 Via Benzinga 7 Biotech Penny Stocks on the Verge of Clinical Trial Victory February 25, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session February 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session February 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 31, 2024 Via Benzinga Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript November 02, 2023 Via The Motley Fool Topics Earnings Exposures Financial Stocks That Hit 52-Week Lows On Wednesday August 30, 2023 Via Benzinga Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript August 02, 2023 Via The Motley Fool Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation July 26, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 18, 2023 Via Benzinga CMG Stock Alert: Chipotle Announces International Expansion Plan July 18, 2023 Via InvestorPlace Why Are Karyopharm Therapeutics Shares Gaining Today? July 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 18, 2023 Via Benzinga Why Is CEL-SCI (CVM) Stock Down 23% Today? July 18, 2023 Via InvestorPlace Why Is Masimo (MASI) Stock Down 30% Today? July 18, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
